Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Eur. j. anat ; 21(3): 173-187, jul. 2017. ilus
Artigo em Inglês | IBECS | ID: ibc-165748

RESUMO

Vitamin B complex has been used for peripheral neuropathy for a long time and continues to be part of current practice despite lack of strong evidence for its use and its non-inclusion in treatment guidelines. So this study was carried out to verify the neuroprotective effect of vitamin B complex from morphological changes of the diabetic rat sciatic nerve. A total number of 30 adult male albino rats were used and divided into three groups. Group I: normal vehicle control (N=10). Group II: streptozotocin-induced diabetic rats (N=20), which is equally divided into two subgroups; IIa (diabetic vehicle control) and IIb (diabetic vitamin B complex-treated, at a dose of 1mg/kg/day for 6 weeks).Diabetes was induced by a single intraperitoneal injection of streptozotocin (STZ) at a dose of 80mg/kg. Specimens from sciatic nerve were processed for light, electron microscopy and immunohistochemistry investigations. Morphological indices including the average myelin sheath thickness, the average myelinated nerve fiber area, endoneurial capillary density and perineurial index were measured and statistically analysed. Vitamin B complex treatment for six weeks markedly protected the sciatic nerve from the deleterious effect of hyperglycemia and preserved normal structural features of the perineurium, Schwann cells and their myelin sheath, nerve fibers, blood capillaries and the interstitium. The results were verified by immunohistochemistry (using CD 31, CD 68 and anti caspase-3 antibodies) and the morphological indices including the myelin sheath thickness, perineurial index and endoneurial capillary density. In conclusion, vitamin B complex supplementation might provide a long-term, drug approach for protection from diabetic peripheral neuropathy


No disponible


Assuntos
Animais , Ratos , Complexo Vitamínico B/farmacocinética , Neuropatias Diabéticas/tratamento farmacológico , Substâncias Protetoras/farmacocinética , Modelos Animais de Doenças , Neuropatias Diabéticas/prevenção & controle , Complicações do Diabetes/prevenção & controle , Fibras Nervosas Mielinizadas , Nervos Periféricos
2.
Eur. j. anat ; 19(4): 371-379, oct. 2015. ilus, tab, graf
Artigo em Inglês | IBECS | ID: ibc-145666

RESUMO

Nephropathy remains an important complication of diabetes. This work was carried out to evaluate the protective effects of N-thioacetylbiguanidine on the diabetic rat kidney. Fifteen adult male Wistar rats were divided into two groups: Group I, control (n=5) and Group II, diabetic group (n=10). The latter was equally divided into two subgroups: IIa (diabetic control) and IIb (diabetic N-thioacetylbiguanidine treated). Specimens were taken from the renal cortex, processed and examined using light, immunohistochemical, ultrastructural and morphometric techniques.The renal cortices from diabetic animals showed dilated glomeruli and tubules and thickening of the glomerular capillary basement membranes. The proximal tubules revealed partial loss of brush border and deposition of PAS-positive material in some distal tubules. iNOS-immunoreactivity was strongly expressed in the renal tubules and glomeruli. The juxtaglomerular (JG) cells revealed no intra-cytoplasmic secretory granules. The histological changes in renal glomeruli and tubules were improved in N-thioacetylbiguanidine treated group. Use of N-thioacetylbiguanidine characteristically reduced iNOS expression in kidney and renin secretion in JG cells. In conclusion, N-thioacetylbiguanidine is effective in attenuating the histological changes of diabetic nephropathy reaching healing features, which resemble that of a normal kidney


No disponible


Assuntos
Animais , Ratos , Nefropatias Diabéticas/tratamento farmacológico , Biguanidas/farmacocinética , Técnicas Histológicas/métodos , Substâncias Protetoras/farmacocinética , Modelos Animais de Doenças
3.
Eur. j. anat ; 19(1): 15-26, ene. 2015. ilus
Artigo em Inglês | IBECS | ID: ibc-133886

RESUMO

The main objective of this study was to investigate the morphological aspects of the development of the Harderian gland (HG) in the female guinea pig. A total number of thirty animals were used and divided according to age into groups, five animals each. Specimens were taken at the following ages; birth, one week, two weeks, three weeks, four weeks and two months postnatal. Histological, histochemical and immunohistochemical techniques were used. The gland was constituted of secretory end pieces and a duct system formed of intra- and extra-parenchymal ducts. At birth, the female guinea pig HG was active in the secretion of lipid and neutral mucin and the differentiation of several populations of cells (light and dark) was possible. However, its histological structure was still incomplete. The lining cells revealed many free ribosomes, a few and small organelles and large irregularly shaped nuclei and numerous mitotic figures. The secretory cells reached maturity by the age of three weeks, but growth in size continued up to the age of two months. They were light or dark; the light cells presented three forms that exhibited different morphological features. All modes of secretion (apocrine, merocrine and holocrine) were detected


No disponible


Assuntos
Animais , Cobaias/crescimento & desenvolvimento , Glândula de Harder/crescimento & desenvolvimento , Glândula de Harder/anatomia & histologia , Microscopia de Polarização/métodos , Glândula de Harder/ultraestrutura
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...